nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.10.2008 | ORIGINAL PAPER

Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder

verfasst von: Fernando Sarramea Crespo, Rogelio Luque, David Prieto, Pablo Sau, Carmen Albert, Itziar Leal, Ana de Luxan, Maria Isabel Osuna, Miguel Ruiz, Rosa Galán, Francisco Cabaleiro, Vicente Molina

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Biochemical changes have been reported in vivo in the brain in schizophrenia patients using 1H-magnetic resonance spectroscopy (MRS). The aim of this study was to assess the specificity of biochemical changes occurring in schizophrenia patients, in a direct comparison with bipolar disorder patients. Fourteen patients with chronic paranoid schizophrenia, 17 euthymic type I bipolar patients with no previous history of psychotic symptoms and 15 healthy controls were included, most of them were female. They underwent a study with MRS: proton spectra were acquired using a Signa 1.5 T CVI scanner, with a localised single voxel PRESS sequence. N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder. Schizophrenia patients showed a significantly higher Cho/Cre as well as lower NAA/Cho ratios as compared with controls and bipolar patients. No significant differences were found among the three groups as regards NAA/Cre levels. These data are consistent with an increase in the concentration of choline in the cingulum in chronic schizophrenia, at least in this predominantly female group. Such an increase seems to be more intense than in psychosis-free bipolar disorder patients.

Amaral JA, Tamada RS, Issler CK, Caetano SC, Cerri GG, de Castro CC, Lafer B (2006) A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients. Hum Psychopharmacol 21:215–220PubMedCrossRef

Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR (2001) The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 49:39–46PubMedCrossRef

Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR (2003) Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging. Biol Psychiatry 53:906–913PubMedCrossRef

Bhakoo KK, Pearce D (2000) In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 74:254–262PubMedCrossRef

Block W, Bayer TA, Tepest R, Traber F, Rietschel M, Muller DJ, Schulze TG, Honer WG, Maier W, Schild HH, Falkai P (2000) Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy study. Neurosci Lett 289:147–151PubMedCrossRef

Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348PubMedCrossRef

Buckley PF, Moore C, Long H, Larkin C, Thompson P, Mulvany F, Redmond O, Stack JP, Ennis JT, Waddington JL (1994) 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 36:792–800PubMedCrossRef

Bush G, Luu P, Posner MI (2000) Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 4:215–222PubMedCrossRef

Cecil KM, DelBello MP, Morey R, Strakowski SM (2002) Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord 4:357–365PubMedCrossRef

10.

Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162–173PubMedCrossRef

11.

Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K (2007) Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol Psychiatry 62:1396–1404PubMedCrossRef

12.

Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450–458PubMedCrossRef

13.

Deicken RF, Zhou L, Schuff N, Weiner MW (1997) Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr Res 27:65–71PubMedCrossRef

14.

Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME (1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386:824–827PubMedCrossRef

15.

Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, Henn FA (2000) Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 41:389–395PubMedCrossRef

16.

Ende G, Walter S, Welzel H, Demirakca T, Wokrina T, Ruf M, Ulrich M, Diehl A, Henn FA, Mann K (2006) Alcohol consumption significantly influences the MR signal of frontal choline-containing compounds. Neuroimage 32:740–746PubMedCrossRef

17.

Frahm J, Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Chien D, Bruhn H (1989) Localized NMR spectroscopy in vivo. Progress and problems. NMR Biomed 2:188–195PubMedCrossRef

18.

Griffin JL, Bollard M, Nicholson JK, Bhakoo K (2002) Spectral profiles of cultured neuronal and glial cells derived from HRMAS (1)H NMR spectroscopy. NMR Biomed 15: 375–384PubMedCrossRef

19.

Hollingshead A FR (1953) Social stratification and psychiatric disorders. Am Soc Rev 18:163–189

20.

Jansen JF, Backes WH, Nicolay K, Kooi ME (2006) 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240:318–332PubMedCrossRef

21.

Jessen F, Scherk H, Traber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W (2006) Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia. Schizophr Res 87:81–88PubMedCrossRef

22.

Katsel P, Davis KL, Haroutunian V (2005) Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr Res 79:157–173PubMedCrossRef

23.

Lee PL, Yiannoutsos CT, Ernst T, Chang L, Marra CM, Jarvik JG, Richards TL, Kwok EW, Kolson DL, Simpson D, Tang CY, Schifitto G, Ketonen LM, Meyerhoff DJ, Lenkinski RE, Gonzalez RG, Navia BA (2003) A multi-center 1H MRS study of the AIDS dementia complex: validation and preliminary analysis. J Magn Reson Imaging 17:625–633PubMedCrossRef

24.

Lewis DA, Lieberman JA (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28:325–334PubMedCrossRef

25.

Moore CM, Breeze JL, Gruber SA, Babb SM, Frederick BB, Villafuerte RA, Stoll AL, Hennen J, Yurgelun-Todd DA, Cohen BM, Renshaw PF (2000) Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. Bipolar Disord 2:207–216PubMedCrossRef

26.

Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK (2000) Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2’s neurotrophic effects? Biol Psychiatry 48:1–8PubMedCrossRef

27.

Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C (2004) A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophr Res 71:405–416PubMedCrossRef

28.

Nopoulos P, Flaum M, Andreasen NC (1997) Sex differences in brain morphology in schizophrenia. Am J Psychiatry 154:1648–1654PubMed

29.

Nudmamud S, Reynolds LM, Reynolds GP (2003) N-acetylaspartate and N-acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study. Biol Psychiatry 53:1138–1141PubMedCrossRef

30.

Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, Igarashi Y, Ohara K (1998) Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 84:55–60PubMedCrossRef

31.

Selemon LD, Lidow MS, Goldman-Rakic PS (1999) Increased volume and glial density in primate prefrontal cortex associated with chronic antipsychotic drug exposure. Biol Psychiatry 46:161–172PubMedCrossRef

32.

Shenton ME, Dickey CC, Frumin M, McCarley RW (2001) A review of MRI findings in schizophrenia. Schizophr Res 49:1–52PubMedCrossRef

33.

Silverstone PH, Wu RH, O’Donnell T, Ulrich M, Asghar SJ, Hanstock CC (2003) Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients. Int Clin Psychopharmacol 18:73–79PubMedCrossRef

34.

Simpson JR Jr, Drevets WC, Snyder AZ, Gusnard DA, Raichle ME (2001) Emotion-induced changes in human medial prefrontal cortex: II. During anticipatory anxiety. Proc Natl Acad Sci USA 98:688–693PubMedCrossRef

35.

Smith SM (2002) Fast robust automated brain extraction. Hum Brain Mapp 17:143–155PubMedCrossRef

36.

Steen RG, Hamer RM, Lieberman JA (2005) Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30:1949–1962PubMedCrossRef

37.

Strakowski SM, DelBello MP, Adler C, Cecil DM, Sax KW (2000) Neuroimaging in bipolar disorder. Bipolar Disord 2:148–164PubMedCrossRef

38.

Strakowski SM, Delbello MP, Adler CM (2005) The functional neuroanatomy of bipolar disorder: a review of neuroimaging findings. Mol Psychiatry 10:105–116PubMedCrossRef

39.

Theberge J, Al-Semaan Y, Drost DJ, Malla AK, Neufeld RW, Bartha R, Manchanda R, Menon R, Densmore M, Schaefer B, Williamson PC (2004) Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla. Psychiatry Res 131:107–114PubMedCrossRef

40.

Todtenkopf MS, Vincent SL, Benes FM (2005) A cross-study meta-analysis and three-dimensional comparison of cell counting in the anterior cingulate cortex of schizophrenic and bipolar brain. Schizophr Res 73:79–89PubMedCrossRef

41.

Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004) Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67:269–275PubMedCrossRef

42.

Urenjak J, Williams SR, Gadian DG, Noble M (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13:981–989PubMed

43.

Webster MJ, O’Grady J, Kleinman JE, Weickert CS (2005) Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Neuroscience 133:453–461PubMedCrossRef

44.

Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA (2000) Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 47:475–481PubMedCrossRef

45.

Yamasue H, Fukui T, Fukuda R, Yamada H, Yamasaki S, Kuroki N, Abe O, Kasai K, Tsujii K, Iwanami A, Aoki S, Ohtomo K, Kato N, Kato T (2002) 1H-MR spectroscopy and gray matter volume of the anterior cingulate cortex in schizophrenia. Neuroreport 13:2133–2137PubMedCrossRef

46.

Zhang Y, Brady M, Smith S (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation–maximization algorithm. IEEE Trans Med Imaging 20:45–57PubMedCrossRef

Titel: Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder
verfasst von: Fernando Sarramea Crespo
Rogelio Luque
David Prieto
Pablo Sau
Carmen Albert
Itziar Leal
Ana de Luxan
Maria Isabel Osuna
Miguel Ruiz
Rosa Galán
Francisco Cabaleiro
Vicente Molina
Publikationsdatum: 01.10.2008
Verlag: D. Steinkopff-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 7/2008
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-008-0808-9

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2008

Age-specific familial risks of anxiety

5-ht2c receptor and mao-a interaction analysis: no association with suicidal behaviour in bipolar patients

Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate

Executive performance of depressed suicide attempters: the role of suicidal ideation